China channel feed – Endpoints News

China channel feed

China startup injects CRISPR therapy into the brain for the first time

2 months ago

Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms

2 months ago

BioNTech-backed ADC maker DualityBio plans IPO on Hong Kong exchange

2 months ago

Amid Trump’s research cuts, commission says US risks losing biotech race without $15B investment

2 months ago

ADC startup DualityBio seeks Hong Kong IPO amid precarious market

2 months ago

China's retaliatory tariffs on US could mean more headwinds for drugmakers

2 months ago

F-star management takes company private, two years after $161M cash exit to Sino's invoX

2 months ago

WuXi Biologics’ licensing deals help offset Biosecure threat in the US

2 months ago

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

2 months ago

AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China

3 months ago

AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron

3 months ago

Ascendis’ China joint venture, Visen Pharmaceuticals, prices $86M Hong Kong IPO

3 months ago

WuXi AppTec's US revenue growth continues to dip in post-Biosecure environment

3 months ago

Merck KGaA says earlier moves to localize manufacturing help ease Trump tariff impact

3 months ago

China bans imports of Illumina's DNA sequencers following US tariffs

3 months ago

En vogue Chinese ADC biotech lets Hong Kong IPO filing lapse

3 months ago

Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos

3 months ago

How Keymed steered the China-to-US NewCo model in biotech

4 months ago

AstraZeneca buys FibroGen’s China unit for local control of anemia drug

4 months ago

FDA puts two Chinese API makers on import alert after failed inspections

4 months ago

Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers, manufacturing partners

4 months ago

Post-Hoc: China tensions both help and hurt Illumina

4 months ago

AstraZeneca offers some detail on China probe, reaffirms commitment to that market

4 months ago

Merck CEO says he’s confident in growth despite Gardasil ‘headwind’

4 months ago

First page Previous page 123 4 5 Next page Last page